Industry Trends Executive Brief: It highlights challenges and strategies healthcare leaders shared as part of their conference presentations. Key topics include opportunities to advance value-based care, methods to build a high-performance organization, and optimal financial strategies to confront security threats. Click "Read more" or "Download" to access the free report.
Multinational pharmaceutical companies neglect the diseases of the tropics, not because the science is impossible but because there is, in the cold economics of the drugs companies, no market.
There is, of course, a market in the sense that there is a need: But there is no market in the sense that, unlike Viagra, medicines for leishmaniasis are needed by poor people in poor countries.
Pharmaceutical companies judge that they would not get sufficient return on research investment, so why, they ask, should we bother? For the large companies, they feel their investment into research and development would suffer if other companies then simply copy what they produce.
Yet, a lot of the base science and research that the large companies have benefited from has been publicly funded—through university programs, government subsidized research, and other health programs. Privatizing such profits may be acceptable to a certain degree.
However, Jamie Love, an AIDS activist, denies that the pharmaceuticals even own the rights to the drugs in the first place. He points out that many of the anti-retroviral drugs used to treat HIV and AIDS today stem from the government-funded cancer drug research of the s.
The rights to government-created innovations were sold to pharmaceutical companies at low prices … guaranteeing companies like Bristol-Myers Squibb huge returns on investment.
Jamie LoveSalon. Economist and director of the Third World NetworkMartin Khor writes, Just as controversial [as patenting living organisms], or even more so, are patents and patent applications relating to plants that have traditionally been used for medicinal and other purposes e.
Many medicines are derived from or based on biochemical compounds originating from plants and biodiversity in the tropical and sub-tropical countries. Much of the knowledge of the use of plants for medical purposes resides with indigenous peoples and local communities.
Scientists and companies from developed countries have been charged with biopiracy when they appropriate the plants or their compounds from the forests as well as the traditional knowledge of the community healers, since patents are often applied for the materials and the knowledge.
Drummond Rennie, from the Journal of the American Medical Associationnoted in a television documentary that Pharmaceuticals, they are a commodity.
But they are not just a commodity. And that gives them altogether a deeper significance. Indeed, I believe that they often forget it completely. Drummond Rennie, transcribed from Dying for Drugs, Channel 4, UK, April 27, However, critics are pointing out that as well as saving lives, they are also taking lives from the poor, especially in the developing world, where, through rich country governments, they have lobbied for policies that will help ensure that their patents are recognized in most countries, thus extending those monopolies on their drugs.
Writer and broadcaster, John Madeley, summarizes a number of concerns raised over the years: Making use of advertising that is inexpensive in comparison to what they pay in industrialized countries, the drug TNCs [Transnational Corporations] use the most persuasive, not to say unethical, methods to persuade the poor to buy their wares.
Extravagant claims are made that would be outlawed in the Western countries. A survey, in the Annals of Internal Medicine found that 62 per cent of the pharmaceutical advertisements in medical journals were either grossly misleading or downright inaccurate. A vivid case is that of South Africa and cheaper generic drugs.
In fact, there was no violation. As problematic as the WTO rules have been in this area, there was provision in the rules allowing generic drugs to be created for emergency situations and public, non-commercial use.
While public outrage managed to get such a move backed down, the underlying concerns from the big pharmaceutical companies have remained, and in various ways since, they have pressured the United States and other rich, industrialized nations to prevent other countries from doing similar things.Explore the trends and issues of the international conference industry and how these trends and issues might impact on the Irish conference market.
The meetings, incentives, conferences and events industry is continuing to grow and develop. Tech Trends It’s all CIOs can do to keep up with each new disruptive technology—blockchain, cognitive, digital reality—and incorporate them into specific organizational domains.
But there’s a better way to understand and use today’s profound changes: to see these technological forces as complementary, working in harmony. WIC accounts for almost 12 percent of total Federal expenditures for food and nutrition assistance.
This report presents comprehensive background information on the WIC program-how it works, its history, program trends, and the characteristics of the population it serves. Five Trends That Are Dramatically Changing Work and the Workplace © Knoll, Inc.
Page 1 The Changing Nature of Work My wife, a manager at Hewlett-Packard, usually has a two minute commute—a thirty foot walk from the.
Issues of medical drugs, how they are researched, developed, patented, made available (or not), priced, etc are all important issues, as also discussed earlier, but research shows how a significant proportion of the global burden of both communicable and non-communicable disease could be reduced through improved preventive action.
Explore the US Elections through Search data Search data is an indication of curiosity in the subject or candidate. It should not be considered an indication of voter intent.